Niagen Bioscience (NAGE) Change in Working Capital (2016)
Niagen Bioscience (NAGE) reported Change in Working Capital of $994000.0 for Q1 2016.
Niagen Bioscience (NAGE) Change in Working Capital (2016) Analysis & Trends
Niagen Bioscience (NAGE) has 1 years of Change in Working Capital data on file, last reported at $994000.0 in Q1 2016.
- Change in Working Capital for Q1 2016 came in at $994000.0, changed N/A year-over-year; the trailing twelve-month figure through Jan 2016 was $994000.0 (changed N/A YoY), and the FY2016 annual result was $994000.0, changed N/A from the prior year.
- Change in Working Capital steadied at $994000.0 in Q1 2016 per NAGE's latest filing.
- Over five years, Change in Working Capital peaked at $994000.0 in Q1 2016 and troughed at $994000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 2, 2016 | 994,000.00 |
| Jan 2, 2016 | 994,000.00 |